Your browser doesn't support javascript.
loading
Cost-effectiveness of incorporating Mycobacterium indicus pranii vaccine to multidrug therapy in newly diagnosed leprosy cases for better treatment outcomes & immunoprophylaxis in contacts as leprosy control measures for National Leprosy Eradication Programme in India.
Muniyandi, Malaisamy; Singh, Malkeet; Singh, Manjula; Rajshekhar, Kavitha; Katoch, Kiran.
Afiliación
  • Muniyandi M; Department of Health Economics, ICMR-National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India.
  • Singh M; Department of Health Research, Ministry of Health & Family Planning, Government of India, New Delhi, India.
  • Singh M; Division of Epidemiology & Communicable Diseases, Indian Council of Medical Research (ICMR), New Delhi, India.
  • Rajshekhar K; Department of Health Research, Ministry of Health & Family Planning, Government of India, New Delhi, India.
  • Katoch K; Distinguished Dr A.S. Paintal Scientist Chair of ICMR at Indian Institute of Health Management Research University, Jaipur, Rajasthan, India.
Indian J Med Res ; 154(1): 121-131, 2021 07.
Article en En | MEDLINE | ID: mdl-34782538
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vacunas / Lepra Tipo de estudio: Diagnostic_studies / Health_economic_evaluation / Incidence_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Indian J Med Res Año: 2021 Tipo del documento: Article País de afiliación: India
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vacunas / Lepra Tipo de estudio: Diagnostic_studies / Health_economic_evaluation / Incidence_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Indian J Med Res Año: 2021 Tipo del documento: Article País de afiliación: India